BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 36091851)

  • 1. PDSTP Is the First Drug in Class to Treat Coronavirus Infection.
    Makarov VA; Popov VO
    Her Russ Acad Sci; 2022; 92(4):488-490. PubMed ID: 36091851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The
    Hu Y; Meng X; Zhang F; Xiang Y; Wang J
    Emerg Microbes Infect; 2021 Dec; 10(1):317-330. PubMed ID: 33560940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A proof-of-concept study for the efficacy of dispirotripiperazine PDSTP in a rabbit model of herpes simplex epithelial keratitis.
    Alimbarova L; Egorova A; Riabova O; Monakhova N; Makarov V
    Antiviral Res; 2022 Jun; 202():105327. PubMed ID: 35487465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparan sulfate proteoglycans as attachment factor for SARS-CoV-2.
    Liu L; Chopra P; Li X; Bouwman KM; Tompkins SM; Wolfert MA; de Vries RP; Boons GJ
    bioRxiv; 2021 Jan; ():. PubMed ID: 32511404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural and Recombinant SARS-CoV-2 Isolates Rapidly Evolve
    Shiliaev N; Lukash T; Palchevska O; Crossman DK; Green TJ; Crowley MR; Frolova EI; Frolov I
    J Virol; 2021 Oct; 95(21):e0135721. PubMed ID: 34406867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LY6E Restricts Entry of Human Coronaviruses, Including Currently Pandemic SARS-CoV-2.
    Zhao X; Zheng S; Chen D; Zheng M; Li X; Li G; Lin H; Chang J; Zeng H; Guo JT
    J Virol; 2020 Aug; 94(18):. PubMed ID: 32641482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Origin and Structural Biology of Novel Coronavirus (SARS-CoV-2).
    Mallick R; Duttaroy AK
    Adv Exp Med Biol; 2021; 1352():1-13. PubMed ID: 35132591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of Syndecans to the Cellular Entry of SARS-CoV-2.
    Hudák A; Letoha A; Szilák L; Letoha T
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparin-binding Peptides as Novel Therapies to Stop SARS-CoV-2 Cellular Entry and Infection.
    Tavassoly O; Safavi F; Tavassoly I
    Mol Pharmacol; 2020 Nov; 98(5):612-619. PubMed ID: 32913137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 and Three Related Coronaviruses Utilize Multiple ACE2 Orthologs and Are Potently Blocked by an Improved ACE2-Ig.
    Li Y; Wang H; Tang X; Fang S; Ma D; Du C; Wang Y; Pan H; Yao W; Zhang R; Zou X; Zheng J; Xu L; Farzan M; Zhong G
    J Virol; 2020 Oct; 94(22):. PubMed ID: 32847856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional interrogation of a SARS-CoV-2 host protein interactome identifies unique and shared coronavirus host factors.
    Hoffmann HH; Schneider WM; Sánchez-Rivera FJ; Luna JM; Ashbrook AW; Soto-Feliciano YM; Leal AA; Le Pen J; Ricardo-Lax I; Michailidis E; Hao Y; Stenzel AF; Peace A; Allis CD; Lowe SW; MacDonald MR; Poirier JT; Rice CM
    bioRxiv; 2020 Sep; ():. PubMed ID: 32935098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dispirotripiperazine-core compounds, their biological activity with a focus on broad antiviral property, and perspectives in drug design (mini-review).
    Egorova A; Bogner E; Novoselova E; Zorn KM; Ekins S; Makarov V
    Eur J Med Chem; 2021 Feb; 211():113014. PubMed ID: 33218683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Kinome-Wide Small Interfering RNA Screen Identifies Proviral and Antiviral Host Factors in Severe Acute Respiratory Syndrome Coronavirus Replication, Including Double-Stranded RNA-Activated Protein Kinase and Early Secretory Pathway Proteins.
    de Wilde AH; Wannee KF; Scholte FE; Goeman JJ; Ten Dijke P; Snijder EJ; Kikkert M; van Hemert MJ
    J Virol; 2015 Aug; 89(16):8318-33. PubMed ID: 26041291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of hepatitis C virus interaction with heparan sulfate proteoglycans.
    Xu Y; Martinez P; Séron K; Luo G; Allain F; Dubuisson J; Belouzard S
    J Virol; 2015 Apr; 89(7):3846-58. PubMed ID: 25609801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Interferon-Inducible Proteoglycan Testican-2/SPOCK2 Functions as a Protective Barrier against Virus Infection of Lung Epithelial Cells.
    Ahn N; Kim WJ; Kim N; Park HW; Lee SW; Yoo JY
    J Virol; 2019 Oct; 93(20):. PubMed ID: 31341044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparan sulfate proteoglycans of human neuroblastoma cells: affinity fractionation on columns of platelet factor-4+.
    Maresh GA; Chernoff EA; Culp LA
    Arch Biochem Biophys; 1984 Sep; 233(2):428-37. PubMed ID: 6237609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a heparan sulfate proteoglycan that copurifies with the neural cell adhesion molecule.
    Cole GJ; Burg M
    Exp Cell Res; 1989 May; 182(1):44-60. PubMed ID: 2523815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia reduces cell attachment of SARS-CoV-2 spike protein by modulating the expression of ACE2, neuropilin-1, syndecan-1 and cellular heparan sulfate.
    Prieto-Fernández E; Egia-Mendikute L; Vila-Vecilla L; Bosch A; Barreira-Manrique A; Lee SY; García-Del Río A; Antoñana-Vildosola A; Jiménez-Lasheras B; Moreno-Cugnon L; Jiménez-Barbero J; Berra E; Ereño-Orbea J; Palazon A
    Emerg Microbes Infect; 2021 Dec; 10(1):1065-1076. PubMed ID: 34013835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acidic and basic fibroblast growth factor bind with differing affinity to the same heparan sulfate proteoglycan on BALB/c 3T3 cells: implications for potentiation of growth factor action by heparin.
    Brown KJ; Hendry IA; Parish CR
    J Cell Biochem; 1995 May; 58(1):6-14. PubMed ID: 7543903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human coronavirus NL63 utilizes heparan sulfate proteoglycans for attachment to target cells.
    Milewska A; Zarebski M; Nowak P; Stozek K; Potempa J; Pyrc K
    J Virol; 2014 Nov; 88(22):13221-30. PubMed ID: 25187545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.